| For: | Oikawa H, Maesawa C, Sato R, Oikawa K, Yamada H, Oriso S, Ono S, Yashima-Abo A, Kotani K, Suzuki K, Masuda T. Liver cirrhosis induced by long-term administration of a daily low dose of amiodarone: A case report. World J Gastroenterol 2005; 11(34): 5394-5397 [PMID: 16149155 DOI: 10.3748/wjg.v11.i34.5394] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i34/5394.htm |
| Number | Citing Articles |
| 1 |
Raúl J. Andrade, Isabel M. Lucena, Neil Kaplowitz, Beatriz García-Muņoz, Yolanda Borraz, Ketevan Pachkoria, Miren García-Cortés, Carmen M. Fernández, Gloria Pelaez, Luis Rodrigo, José A. Durán, Joan Costa, Ramón Planas, Anabel Barriocanal, Carlos Guarner, Manuel Romero-Gomez, Teresa Muņoz-Yagüe, Javier Salmerón, Ramón Hidalgo. Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry. Hepatology 2006; 44(6) doi: 10.1002/hep.21424
|
| 2 |
Lucía Llanos, Rocío Moreu, Ana M Peiró, Sonia Pascual, Rubén Francés, José Such, José F. Horga, Miguel Pérez‐Mateo, Pedro Zapater. Causality assessment of liver injury after chronic oral amiodarone intake. Pharmacoepidemiology and Drug Safety 2009; 18(4) doi: 10.1002/pds.1709
|
| 3 |
Sunao Kojima, Shinobu Kojima, Hirofumi Ueno, Motohiro Takeya, Hisao Ogawa, Josep Brugada. Increased Density of the Liver and Amiodarone‐Associated Phospholipidosis. Cardiology Research and Practice 2009; 2009(1) doi: 10.4061/2009/598940
|
| 4 |
Sampada A. Shahane, Ruili Huang, David Gerhold, Ulrich Baxa, Christopher P. Austin, Menghang Xia. Detection of Phospholipidosis Induction: A Cell-Based Assay in High-Throughput and High-Content Format. SLAS Discovery 2014; 19(1) doi: 10.1177/1087057113502851
|
| 5 |
Einar Björnsson, Loa Davidsdottir. The long-term follow-up after idiosyncratic drug-induced liver injury with jaundice. Journal of Hepatology 2009; 50(3) doi: 10.1016/j.jhep.2008.10.021
|
| 6 |
Dina Halegoua-De Marzio, Victor J. Navarro. Drug-Induced Liver Disease. 2013; doi: 10.1016/B978-0-12-387817-5.00029-7
|
| 7 |
|
| 8 |
Jason Ta, Ritesh Bhandari, Joseph Di Francesco, Austin Roberts, Eileen Long, Puneet Chhabra, Junaid Beig, Yoshifumi Nakayama. Smoldering Amiodarone‐Induced Decompensated Cirrhosis: Cumulative Dose–Related Toxicity. Case Reports in Gastrointestinal Medicine 2026; 2026(1) doi: 10.1155/crgm/9933788
|
| 9 |
Kenichi Kishimoto, Hiroshi Tobita, Masatoshi Kataoka, Tomotaka Yazaki, Akihiko Oka, Norihisa Ishimura, Kazuaki Tanabe, Shunji Ishihara. Changes in Hepatic Density Due to Oral Amiodarone-induced Liver injury Shown by Computed Tomography. Internal Medicine 2025; 64(12) doi: 10.2169/internalmedicine.4436-24
|
| 10 |
Davide Germano, Marianne Uteng, Francois Pognan, Salah-Dine Chibout, Armin Wolf. Determination of liver specific toxicities in rat hepatocytes by high content imaging during 2-week multiple treatment. Toxicology in Vitro 2015; 30(1) doi: 10.1016/j.tiv.2014.05.009
|
| 11 |
Narci C. Teoh, Shivakumar Chitturi, Geoffrey C. Farrell. Sleisenger and Fordtran's Gastrointestinal and Liver Disease. 2010; doi: 10.1016/B978-1-4160-6189-2.00086-X
|
| 12 |
Nasir Hussain, Anirban Bhattacharyya, Suartcha Prueksaritanond. Amiodarone-Induced Cirrhosis of Liver: What Predicts Mortality?. ISRN Cardiology 2013; 2013 doi: 10.1155/2013/617943
|
| 13 |
Li Zhang, Shuaizhang Li, Menghang Xia. High-Throughput Screening Assays in Toxicology. Methods in Molecular Biology 2022; 2474 doi: 10.1007/978-1-0716-2213-1_8
|
| 14 |
J.K. Aronson. A worldwide yearly survey of new data and trends in adverse drug reactions and interactions. Side Effects of Drugs Annual 2008; 30 doi: 10.1016/S0378-6080(08)00017-2
|
| 15 |
E. BJÖRNSSON, E. KALAITZAKIS, V. AV KLINTEBERG, N. ALEM, R. OLSSON. Long‐term follow‐up of patients with mild to moderate drug‐induced liver injury. Alimentary Pharmacology & Therapeutics 2007; 26(1) doi: 10.1111/j.1365-2036.2007.03355.x
|
| 16 |
Inmaculada Medina-Caliz, Mercedes Robles-Diaz, Beatriz Garcia-Muñoz, Camilla Stephens, Aida Ortega-Alonso, Miren Garcia-Cortes, Andres González-Jimenez, Judith A. Sanabria-Cabrera, Inmaculada Moreno, M. Carmen Fernandez, Manuel Romero-Gomez, Jose M. Navarro, Ana Mª Barriocanal, Eva Montane, Hacibe Hallal, Sonia Blanco, German Soriano, Eva M. Roman, Elena Gómez-Dominguez, Agustin Castiella, Eva M. Zapata, Miguel Jimenez-Perez, Jose M. Moreno, Ana Aldea-Perona, Manuel Hernández-Guerra, Martin Prieto, Miguel E. Zoubek, Neil Kaplowitz, M. Isabel Lucena, Raul J. Andrade. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury. Journal of Hepatology 2016; 65(3) doi: 10.1016/j.jhep.2016.05.003
|
| 17 |
E. Björnsson. Review article: drug‐induced liver injury in clinical practice. Alimentary Pharmacology & Therapeutics 2010; 32(1) doi: 10.1111/j.1365-2036.2010.04320.x
|
| 18 |
Aida Ortega‐Alonso, Raúl J Andrade. Chronic liver injury induced by drugs and toxins. Journal of Digestive Diseases 2018; 19(9) doi: 10.1111/1751-2980.12612
|
| 19 |
Mark E. Schurdak, Lawrence A. Vernetti, Stephen J. Abel, Christine Thiffault. Adaptation of an In Vitro Phospholipidosis Assay to an Automated Image Analysis System. Toxicology Mechanisms and Methods 2007; 17(2) doi: 10.1080/15376510600860185
|
| 20 |
Stéphanie Espiard, Anne-Sophie Balavoine, Fanny Mouton, Stéphanie Fry, Marie-Christine Vantyghem, Jean-Louis Wémeau. Troubles endocriniens chez une patiente polymédicamentée. La Presse Médicale 2013; 42(3) doi: 10.1016/j.lpm.2012.01.036
|
| 21 |
Kazuto Tajiri, Yukihiro Shimizu. Practical guidelines for diagnosis and early management of drug-induced liver injury. World Journal of Gastroenterology 2008; 14(44): 6774-6785 doi: 10.3748/wjg.14.6774
|
| 22 |
Raúl J. Andrade, Guruprasad P. Aithal, Einar S. Björnsson, Neil Kaplowitz, Gerd A. Kullak-Ublick, Dominique Larrey, Tom H. Karlsen. EASL Clinical Practice Guidelines: Drug-induced liver injury. Journal of Hepatology 2019; 70(6) doi: 10.1016/j.jhep.2019.02.014
|
| 23 |
|
| 24 |
Masazumi Matsuda, Aoi Otaka, Tomoki Tozawa, Tomoyuki Asano, Koichi Ishiyama, Manabu Hashimoto. Analysis of computed tomography density of liver before and after amiodarone administration. Japanese Journal of Radiology 2018; 36(5) doi: 10.1007/s11604-018-0733-4
|
| 25 |
S Hyder Hussaini, Elizabeth A Farrington. Idiosyncratic drug-induced liver injury: an overview. Expert Opinion on Drug Safety 2007; 6(6) doi: 10.1517/14740338.6.6.673
|
| 26 |
Einar S. Björnsson, Raul J. Andrade. Long-term sequelae of drug-induced liver injury. Journal of Hepatology 2022; 76(2) doi: 10.1016/j.jhep.2021.10.011
|
| 27 |
José C. De la Flor, Pablo Rodríguez-Doyágüez, Daniel Villa, Rocío Zamora, Francisco Díaz. Double Hit of Hydroxichloroquine and Amiodarone Induced Renal Phospholipidosis in a Patient with Monoclonal Gammopathy and Sclerodermiform Syndrome: A Case Report and Review of the Literature. Medical Sciences 2024; 12(2) doi: 10.3390/medsci12020025
|
| 28 |
M. James Lopez, Jacob L. Bilhartz. Diseases of the Liver in Children. 2014; doi: 10.1007/978-1-4614-9005-0_19
|
| 29 |
Brian C. Ferslew, Kim L. R. Brouwer. Identification of Hepatic Phospholipidosis Inducers in Sandwich-Cultured Rat Hepatocytes, a Physiologically Relevant Model, Reveals Altered Basolateral Uptake and Biliary Excretion of Anionic Probe Substrates. Toxicological Sciences 2014; 139(1) doi: 10.1093/toxsci/kfu033
|
| 30 |
Chandrashekaran Girish, Sukumaran Sanjay. Role of immune dysfunction in drug induced liver injury. World Journal of Hepatology 2021; 13(11): 1677-1687 doi: 10.4254/wjh.v13.i11.1677
|
| 31 |
|
| 32 |
连辉 吴. Severe Liver Injury Caused By Long-Term Oral Low-Dose Amiodarone: A Case Report and Literature Review. Asian Case Reports in Vascular Medicine 2024; 12(01) doi: 10.12677/acrvm.2024.121001
|